🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Hudson Technologies secures Chemours licensing deal

EditorEmilio Ghigini
Published 06/05/2024, 14:06
HDSN
-

WOODCLIFF LAKE, N.J. - Hudson (NYSE:HUD) Technologies, Inc. (NASDAQ: HDSN), a prominent player in the refrigerant services industry, announced today a licensing agreement with The Chemours Company (NYSE:CC).

This deal enables Hudson to market its reclaimed refrigerants using the well-known Freon™ brand name, a move that is expected to enhance the visibility of its sustainable refrigerant solutions.

Under the terms of the agreement, Hudson Technologies will have the rights to sell its reclaimed refrigerants under the Freon™ R-11, R-12, R-123, and R-22 labels. Additionally, the company can use the Freon™ brand in its marketing materials for these products.

Brian F. Coleman, President and CEO of Hudson Technologies, expressed satisfaction with the partnership, emphasizing the importance of making high-quality reclaimed refrigerants available to customers during the ongoing phase-out of certain refrigerants.

Doug Westerhoff, Americas Sales Director at Chemours, highlighted the commitment of both companies to pioneering sustainable refrigerant products and practices. The partnership is seen as a step forward in promoting lifecycle refrigerant management and transitioning to next-generation refrigerants in line with the American Innovation and Manufacturing (AIM) Act's objectives.

Hudson Technologies has been a significant force in the refrigerant reclamation industry for nearly three decades. The company has invested heavily in technology to recover a wide array of refrigerants and restore them to industry standards for reuse.

Their services include the sale of refrigerants and industrial gases, refrigerant management, and system decontamination. Additionally, Hudson offers web-based real-time monitoring services, predictive and diagnostic services, and generates carbon offset projects.

The announcement is based on a press release statement.

InvestingPro Insights

In light of Hudson Technologies' (NASDAQ: HDSN) recent licensing agreement with The Chemours Company, a look at the company's financial metrics and analyst insights provides a deeper understanding of its market position. According to InvestingPro data, Hudson Technologies holds a market capitalization of 415.51 million USD, which reflects the size of the company in the competitive landscape. The company's Price to Earnings (P/E) Ratio stands at an attractive 9.33, indicating that the stock may be undervalued when compared to industry peers. This is further supported by an adjusted P/E Ratio for the last twelve months as of Q1 2024, which is even lower at 8.98.

Despite recent challenges, with revenue growth experiencing a decline of 12.89% over the last twelve months as of Q1 2024, Hudson Technologies maintains a strong operating income margin of 24.65%, suggesting effective cost management and operational efficiency. This financial stability is reinforced by an InvestingPro Tip that highlights the company's liquidity, noting that Hudson holds more cash than debt on its balance sheet, which could provide resilience in volatile market conditions.

Another InvestingPro Tip points to the stock's recent performance, where the Relative Strength Index (RSI) suggests that HDSN is currently in oversold territory. This could indicate a potential buying opportunity for investors looking to capitalize on short-term price movements. For those interested in a deeper dive into Hudson Technologies' performance and potential, additional insights are available on InvestingPro, including 15 more InvestingPro Tips for HDSN. To access these insights and make more informed decisions, readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

As the company forges ahead with sustainable initiatives and strategic partnerships, these financial metrics and insights could be valuable for investors considering Hudson Technologies' stock for their portfolios.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.